- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
STRATEC Biomedical AG (SBSG)
STRATEC Biomedical AG stock price live, this page displays ETR SBSG stock exchange data. View the SBSG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the STRATEC Biomedical AG real time stock price chart below.
What Is the STRATEC Biomedical AG Stock Price Today?
The STRATEC Biomedical AG stock price today is 22.000.
What Is the Stock Symbol for STRATEC Biomedical AG?
The stock symbol for STRATEC Biomedical AG is "SBSG."
What Stock Exchange Does STRATEC Biomedical AG Trade On?
STRATEC Biomedical AG is listed and trades on the Xetra stock exchange.
Is STRATEC Biomedical AG a Good Stock to Buy?
Determining whether STRATEC Biomedical AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SBSG quote. (ISIN: DE000STRA555)
What Is the STRATEC Biomedical AG Stock Price Today?
The STRATEC Biomedical AG stock price today is 22.000.
What Is the Stock Symbol for STRATEC Biomedical AG?
The stock symbol for STRATEC Biomedical AG is "SBSG."
What Stock Exchange Does STRATEC Biomedical AG Trade On?
STRATEC Biomedical AG is listed and trades on the Xetra stock exchange.
Is STRATEC Biomedical AG a Good Stock to Buy?
Determining whether STRATEC Biomedical AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SBSG quote. (ISIN: DE000STRA555)
22.000
+1.850(+9.18%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.800
22.600
52 wk Range
16.300
33.100
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.80022.600
52 wk Range
16.30033.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.98%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.98%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SBSG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
25.600
Upside
+16.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Why is STRATEC Biomedical stock surging today?- Investing.com
- Why is STRATEC Biomedical stock surging today?
- Investing.com
STRATEC SE receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 25.600
(+16.36% Upside)
STRATEC Biomedical AG Earnings Call Summary for Q2/2026
- H1 2026 revenue fell 5.1% to EUR 112.5M, but Q2 adjusted EBIT margin surged to 11.9% from Q1's 5.4%, driving 9.68% stock gain to $22.1.
- Free cash flow improved sharply to EUR 23.5M from negative EUR 14.7M year-over-year; system sales rose 15.4% while consumables weakened.
- Management reaffirmed 2026 guidance: mid-to-high single-digit sales growth, ~10% EBIT margin, with Q4 expected to deliver 34-35% of annual revenue.
- Long-term targets maintained: 6-8% CAGR through 2028, then 10-12% through 2030, with EBIT margins reaching 13% by 2028 and 15% by 2030.
- Supply chain pressures persist for electronics; molecular diagnostics recovery remains flat; customer inventory optimization weighing on consumables demand.
Last Updated: 08/14/2026, 09:08 PM
Read Full TranscriptEarnings
Latest Release
May 11, 2026
EPS / Forecast
-0.12 / --
Revenue / Forecast
53.4M / --
Compare SBSG to Peers and Sector
Metrics to compare | SBSG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBSGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −78.6x | −2.6x | −0.4x | |
PEG Ratio | 0.66 | 0.06 | 0.00 | |
Price/Book | 1.1x | 1.1x | 2.6x | |
Price / LTM Sales | 1.1x | 1.5x | 3.1x | |
Upside (Analyst Target) | 4.5% | 34.2% | 47.8% | |
Fair Value Upside | Unlock | 3.0% | 6.2% | Unlock |
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the STRATEC Biomedical (SBSG) Stock Price Today?
The STRATEC Biomedical stock price today is 22.000 EUR.
What Stock Exchange Does STRATEC Biomedical Trade On?
STRATEC Biomedical is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for STRATEC Biomedical?
The stock symbol for STRATEC Biomedical is "SBSG."
Does STRATEC Biomedical Pay Dividends? What’s The Current Dividend Yield?
The STRATEC Biomedical dividend yield is 2.98%.
What Is the STRATEC Biomedical Market Cap?
As of today, STRATEC Biomedical market cap is 267.430M EUR.
What Is STRATEC Biomedical's Earnings Per Share (TTM)?
The STRATEC Biomedical EPS (TTM) is -0.280.
When Is the Next STRATEC Biomedical Earnings Date?
STRATEC Biomedical will release its next earnings report on Aug 17, 2026.
From a Technical Analysis Perspective, Is SBSG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has STRATEC Biomedical Stock Split?
STRATEC Biomedical has split 1 times.
How Many Employees Does STRATEC Biomedical Have?
STRATEC Biomedical has 1395 employees.
What is the current trading status of STRATEC Biomedical (SBSG)?
As of Aug 15, 2026, STRATEC Biomedical (SBSG) is trading at a price of 22.000 EUR, with a previous close of 20.150 EUR. The stock has fluctuated within a day range of 20.800 EUR to 22.600 EUR, while its 52-week range spans from 16.300 EUR to 33.100 EUR.
What Is STRATEC Biomedical (SBSG) Price Target According to Analysts?
The average 12-month price target for STRATEC Biomedical is 25.600 EUR, with a high estimate of 37 EUR and a low estimate of 21 EUR. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +16.36% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.